New Thought Leader for Agilent

Skip to Navigation

Blog Post

  • Published: Jul 21, 2015
  • Author: Jon Evans
  • Suppliers: Agilent Technologies
  • Channels: Proteomics & Genomics / Gas Chromatography / Sample Preparation / HPLC / Ion Chromatography / Laboratory Informatics / Detectors / Electrophoresis / Infrared Spectroscopy / Raman / Chemometrics & Informatics / Atomic / Proteomics / X-ray Spectrometry / NMR Knowledge Base / MRI Spectroscopy / UV/Vis Spectroscopy / Base Peak

View comments on this post

Agilent Technologies has presented its latest Thought Leader Award to Lawrence Lesko, director of the Center for Pharmacometrics and Systems Pharmacology at the University of Florida’s College of Pharmacy in Orlando, US. Agilent's Thought Leader program promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences and chemical analysis.

Keller is being recognized for his research into preclinical toxicological assessments of new medicines. He and his team are using Agilent's Q-TOF LC/MS systems and its Mass Profiler Professional and Pathway Architect software to collect and analyze metabolomics data, with the aim of discovering biomarker panels that could allow the development of companion diagnostics.

'We are pleased to support Dr. Lesko’s research, which is addressing important needs in the rapidly evolving field of systems toxicology,' said Monty Benefiel, Agilent vice president and general manager of the mass spectrometry division, and executive sponsor of the award.

'I am very pleased and appreciative of Agilent’s Thought Leader Award,' said Lesko. 'It enables our team to identify metabolomic safety biomarkers of drug-induced renal toxicity and the mechanisms by which these toxicities occur. This research will lead us to identifying at-risk patients and exploring the use of concomitantly administered medicines as protectants against drug-induced renal damage. It could have a major effect on improving drug development and clinical care.'

(Photo of Lawrence Lesko courtesy of the University of Florida.)

Comments

There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share

Microsites

Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in spectroscopy? Visit our sister site spectroscopyNOW.com

Copyright © 2017 John Wiley & Sons, Inc. All Rights Reserved